Skip to main content
. 2021 Aug 12;13(8):1243. doi: 10.3390/pharmaceutics13081243

Table 2.

DLS analysis of DT (DPPC:TEL), DC (DPPC:Chol) and DD (DPPC:DOPE). Curcumin-loaded liposomes nebulised via vibrating-mesh (PARI VELOX®) and air-jet nebulisation (PARI BOY® SX) were compared with each other, respectively. Unnebulised curcumin-loaded liposomes were used as control. Values of particle size represent the distribution by intensity. Independent formulations were used to measure the triplicates and all results were expressed as mean ± standard deviation.

Lipid
Compositions
Size (nm)
± SD
PdI 1 ± SD ζ-Potential (mV)
± SD
DT 129.7 ± 3.2 0.19 ± 0.08 −13.53 ± 2.42
CUR-liposomes DC
DD
109.4 ± 2.4
94.4 ± 5.9
0.14 ± 0.09
0.26 ± 0.11
−5.61 ± 0.79
−2.97 ± 0.81
Nebulised
(PARI VELOX®)
CUR-liposomes
DT
DC
DD
131.1 ± 3.0
116.4 ± 3.2
99.1 ± 5.2
0.21 ± 0.06
0.18 ± 0.07
0.30 ± 0.09
−16.33 ± 1.95
−3.74 ± 0.64
−2.86 ± 0.59
Nebulised
(PARI BOY® SX)
CUR-liposomes
DT
DC
DD
129.5 ± 2.8
113.3 ± 3.5
100.7 ± 4.7
0.20 ± 0.08
0.21 ± 0.09
0.32 ± 0.08
−15.54 ± 2.13
−5.13 ± 0.92
−3.11 ± 0.76
Lyophilised &
nebulised (VELOX®)
CUR-liposomes
DT
DC
DD
149.6 ± 4.1
127.7 ± 4.8
132.1 ± 5.1
0.46 ± 0.10
0.47 ± 0.13
0.57 ± 0.13
−37.89 ± 4.43
−11.47 ± 2.38
−9.62 ± 2.09

1 Polydispersity index.